Clinical TrialsSearch results
Number of results: 857
Other
- Prospective, randomized, open-label, blinded-endpoint trial to examine the effect of active vitamin D on cardiovascular events in hemodialysis patients: Japan Dialysis Active Vitamin D trial (J-DAVID)
- Chronic kidney disease stage 5D
- J-DAVID Research Group
- 2008-06-19
Other
- Prospective study of the severity-based treatment protocol for Japanese patients with MPO-ANCA-associated vasculitis
- MPO-ANCA-associated vasculitis
- Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan
- 2007-10-30
Other
- Prospective Study of hyperphosphatemia in CKD5D patients undergoing hemodialysis (STOP-HD).
- Hemodialysis patients with hyperphosphatemia
- Phosphate Research group
- 2009-05-25
Other
- Prospective Ramdomized Trial of Extracranial-intracranial (EC-IC) Bypass Surgery for Adults with Moyamoya Disease with Hemorrhagic Onset
- Moyamoya disease
- JAM Trial executive and steering committee
- 2005-09-13
Other
- Prospective phase II study of stereotactic body radiation therapy using helical tomotherapy for stage IA non-small cell lung cancer.
- stage IA non-small cell lung cancer
- Aichi Cancer Center Hospital
- 2009-02-20
Other
- Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
- Refractory (drug resistant) nephrotic syndrome
- the Japanese Society of Kidney and Lipids Research
- 2007-11-01
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Primary Hyperaldosteronism in Japan
- hypertension
- National Hospital Organization
- 2008-02-01
Other
- Prednisolone therapy of the first episode of idopatic nephrotic syndrome in children: A Multi-center randomized controlled trial
- Idiopatic nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2007-09-01
Other
- Predetermined Minor Histocompatibility Antigen-based Therapeutic or Prophylactic Peptide Vaccinations for Patients with Recurred Malignancies or Patients with High-Risk Malignancies Follwoing Allogeneic Hematopoietic Cell Transplantation.
- (1) Therapeutic vaccine: Any hematological malignancies recurred after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML, ALL, CML, Multiple Myeloma, NHL). (2) Prophylactic vaccine: Hematological malignancies with high risk of relapse after allogineic hematopoietic transplanation as follows (RAEB, CMML, AML in >=3CR/non-CR or any AML with M0/M6/M7 FAB type, ALL in >=2CR/non-CR, CML in >=2CP or >=AP, Multiple Myeloma in PD, NHL in non-CR).
- Aichi Cancer Center Research Institute
- 2007-11-01